PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION lobbying for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$4,112,554.00

What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

ANTHONY BUSH New on this filing

Previously held: Legislative Assistant, House Committee on Oversight and Reform, Majority Staff Research Assistant, House Committee on Oversight and Reform, Majority Staff Personal Assistant to Rep. Elijah Cummings

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 5

Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 16

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HR 2214
DRUG Act
HR 2450
Prescription Drug Transparency and Affordability Act
HR 950
Saving Seniors Money on Prescriptions Act
HR 2041
Hidden Fee Disclosure Act of 2025
S 864
HELP Copays Act
S 882
Patients Before Middlemen Act
S 927
Protecting Pharmacies in Medicaid Act
S 832
EPIC Act of 2025
S 1041
Affordable Prescriptions for Patients Act
S 1040
Drug Competition Enhancement Act
S 526
Pharmacy Benefit Manager Transparency Act of 2025
S 527
Prescription Pricing for the People Act of 2025
S 1095
Stop STALLING Act
S 1302
Increasing Transparency in Generic Drug Applications Act
S 2484
Expanding Nationwide Access to Test Strips Act

Lobbying activity 3

Medicare/Medicaid

H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act

Health Issues

H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act

Pharmacy

H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act